Upgrade to SI Premium - Free Trial

Evoke Pharma (EVOK) Tops Q4 EPS by 7c

March 15, 2017 4:09 PM

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.12), $0.07 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

Categories

Earnings Guidance